Skip to main content

Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry.

Publication ,  Journal Article
Cusatis, R; Flynn, KE; Vasu, S; Pidala, J; Muffly, L; Uberti, J; Tamari, R; Mattila, D; Mussetter, A; Bruzauskas, R; Chen, M; Leckrone, E ...
Published in: Transplant Cell Ther
February 2022

The importance of patient-reported outcomes (PROs) in cellular therapies, including hematopoietic cell transplantation (HCT) is highlighted in this study. Longitudinal collection of PROs in a registry is recommended for several reasons, yet to date, PROs are not routinely collected from HCT patients to augment clinical registry data. The aim of this study was to determine the feasibility of electronic PRO data collection by a national clinical outcomes registry, by assessing differences between who does and does not report PROs. We conducted a cross-sectional pilot collection of PROs from HCT recipients after treatment using computer-adapted tests from the Patient-Reported Outcome Measurement Information System (PROMIS). We implemented centralized data collection through the Center for International Blood and Marrow Transplant Research (CIBMTR) among patients who underwent HCT for myelodysplastic syndromes (MDS), were at least 6 months post-HCT, and spoke English or Spanish. The main objective was identifying patient, disease, and transplant-related differences associated with completion of electronic PROs. Patients were excluded from analysis if they were determined to be ineligible (deceased, did not speak English or Spanish, refused to be contacted by the CIBMTR). A total of 163 patients were contacted and potentially eligible to participate; of these, 92 (56%) enrolled and 89 (55%) completed the PRO assessment. The most frequent reason for incomplete surveys was inability to contact patients (n = 88), followed by declining to participate in the study (n = 37). There were no sociodemographic or age differences between those who completed the PRO survey (n = 89) and eligible nonresponders (n = 155). Patient scores were within 3 points of the US average of 50 for all symptoms and functioning except physical functioning. Responders and nonresponders did not exhibit meaningfully different sociodemographic characteristics. Difficulty contacting patients posed the greatest barrier and also provided the greatest opportunity for improvement. Once enrolled, survey completion was high. These results support standardizing centralized PRO data collection through the CIBMTR registry.

Duke Scholars

Published In

Transplant Cell Ther

DOI

EISSN

2666-6367

Publication Date

February 2022

Volume

28

Issue

2

Start / End Page

112.e1 / 112.e9

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Registries
  • Patient Reported Outcome Measures
  • Information Systems
  • Immunology
  • Humans
  • Electronics
  • Cross-Sectional Studies
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cusatis, R., Flynn, K. E., Vasu, S., Pidala, J., Muffly, L., Uberti, J., … Shaw, B. (2022). Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. Transplant Cell Ther, 28(2), 112.e1-112.e9. https://doi.org/10.1016/j.jtct.2021.10.016
Cusatis, Rachel, Kathryn E. Flynn, Sumithira Vasu, Joseph Pidala, Lori Muffly, Joseph Uberti, Roni Tamari, et al. “Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry.Transplant Cell Ther 28, no. 2 (February 2022): 112.e1-112.e9. https://doi.org/10.1016/j.jtct.2021.10.016.
Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, et al. Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. Transplant Cell Ther. 2022 Feb;28(2):112.e1-112.e9.
Cusatis, Rachel, et al. “Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry.Transplant Cell Ther, vol. 28, no. 2, Feb. 2022, pp. 112.e1-112.e9. Pubmed, doi:10.1016/j.jtct.2021.10.016.
Cusatis R, Flynn KE, Vasu S, Pidala J, Muffly L, Uberti J, Tamari R, Mattila D, Mussetter A, Bruzauskas R, Chen M, Leckrone E, Myers J, Mau L-W, Rizzo JD, Saber W, Horowitz M, Lee SJ, Burns LJ, Shaw B. Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry. Transplant Cell Ther. 2022 Feb;28(2):112.e1-112.e9.

Published In

Transplant Cell Ther

DOI

EISSN

2666-6367

Publication Date

February 2022

Volume

28

Issue

2

Start / End Page

112.e1 / 112.e9

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Registries
  • Patient Reported Outcome Measures
  • Information Systems
  • Immunology
  • Humans
  • Electronics
  • Cross-Sectional Studies
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences